Ligand validation:6WTT

B1S: (1R,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid

B1S is a Ligand Of Interest in 6WTT designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6WTT_B1S_C_401	61%	9%	0.152	0.962	2.28	2.13	8	11	0	0	88%	0.8788
7CB7_B1S_A_403	85%	7%	0.073	0.958	3.4	1.53	8	7	0	0	88%	0.4658
7TGR_B1S_A_402	77%	8%	0.085	0.945	2.1	2.51	4	9	0	0	88%	0.3252
7K0G_B1S_A_402	75%	27%	0.1	0.953	1.55	1.39	4	6	0	0	88%	0.4394
8DD9_B1S_A_401	43%	8%	0.178	0.922	3	1.7	8	10	0	0	88%	0.703
8DGB_B1S_A_401	37%	8%	0.201	0.921	3.03	1.63	9	7	0	0	88%	0.8788
5WKJ_B1S_A_403	70%	13%	0.108	0.948	2.71	1.34	8	6	0	0	88%	0.4394
8E7N_B1S_B_402	60%	1%	0.108	0.915	7.38	1.51	17	6	0	0	88%	0.4482

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.